Vitamins-based treatment of for Human Leukemia: 1α,25-dihydroxyvitamin D(3) suppresses the expression of oncogenic Ribonuclease-L via up regulation of its target gene, 26/July/2014, 04.46 am

Vitamins-based treatment of for Human Leukemia: 1α,25-dihydroxyvitamin D(3) suppresses the expression of oncogenic Ribonuclease-L via up regulation of its target gene, 26/July/2014, 04.46 am

Vitamins-based treatment of for Human Leukemia: 1α,25-dihydroxyvitamin D(3) suppresses the expression of oncogenic Ribonuclease-L via up regulation of its target gene, 26/July/2014, 04.46 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan, L.,  Vitamins-based treatment for Human Leukemia: 1α,25-dihydroxyvitamin D(3) suppresses the expression of oncogenic Ribonuclease-L via up regulation of its target gene, 26/July/2014, 04.46 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

 * Research cooperation
Share
Start Typing